Summary
Two hypotheses exist to explain the Down syndrome (DS) phenotype. The “gene dosage effect” hypothesis states that the phenotype is a direct result of the cumulative effect of the imbalance of the individual genes located on the triplicated chromosome or chromosome region. In a nut shell, the phenotype results directly from the overexpression of specific chromosome 21 genes. The “amplified developmental instability” hypothesis contends that most manifestations of DS may be interpreted as the results of a non-specific disturbance of chromosome balance, resulting in a disruption of homeostasis. This hypothesis was proposed in an attempt to explain the similarities between the phenotypes of different aneuploid states and the observation that all of the phenotypic traits in DS are also seen in the general population but at lower frequency, with less severity and usually only present as a single trait. Herein, we review recent data and present evidence to support the theory that the phenotypic traits of aneuploid syndromes, and DS in particular, result from the increased dosage of genes encoded on the triplicated chromosome.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahlbom BE, Goetz P, Korenberg JR, Pettersson U, Seemanova E, Wadelius C, Zech L, Anneren G (1996) Molecular analysis of chromosome 21 in a patient with a pheno-type of Down syndrome and apparently normal karyotype. Am J Med Genet 63: 566–572
Barden HS (1980) Fluctuating dental asymmetry: a measure of developmental instability in Down syndrome. Am J Phys Anthropol 52: 169–173
Blum-Hoffmann E, Rehder H, Langenbeck U (1988) Skeletal anomalies in trisomy 21 as an example of amplified developmental instability in chromosome disorders: a histological study of the feet of 21 mid-trimester fetuses with trisomy 21. Am J Med Genet 29: 155–160
Breg WR (1977) Down syndrome: a review of recent progress in research. Pathobiol Annu 7: 257–303
Caviedes P, Ault B, Rapoport SI (1990) Electrical membrane properties of cultured dorsal root ganglion neurons from trisomy 19 mouse fetuses: a comparison with the trisomy 16 mouse fetus, a model for Down syndrome. Brain Res 511: 169–172
Coussons-Read ME, Crnic LS (1996) Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field. Behav Genet 26: 7–13
Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, Harris BS, Bronson RT (1993) Segmental trisomy as a mouse model for DS. In: Epstein CJ (ed) The pheno-typic mapping of Down syndrome and other aneuploid conditions. John Wiley, New York, pp 117–133
Dunlap SS, Aziz MA, Rosenbaum KN (1986) Comparative anatomical analysis of human trisomies 13, 18 and 21: the forelimb. Teratology 33: 159–186
Epstein CJ (1986) The consequences of chromosome imbalance: principles, mechanisms and models. Cambridge University Press, New York
Epstein CJ (1988) Specificity versus nonspecificity in the pathogenesis of aneuploid phenotypes. Am J Med Genet 29: 161–165
Escorihuela RM, Fernández-Teruel A, Vallina IF, Baamonde C, Lumbreras MA, Dierssen M, Tobeña A, Flórez J (1995) Behavioral assessment of Ts65Dn mice: a putative DS model. Neurosci Lett 199: 143–146
Ferencz C, Neill CA, Boughman JA, Rubin JD, Brenner JI, Perry LW (1989) Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr 114: 79–86
Gearhart JD, Davisson MT, Oster-Granite ML (1986) Autosomal aneuploidy in mice: generation and developmental consequences. Brain Res Bull 16: 789–801
Greber-Platzer S, Schatzmann-Turhani D, Wollenek G, Lubec G (1999) Evidence against the current hypothesis of “gene dosage effects” of trisomy 21: Ets-2, encoded on chromosome 21 is not overexpressed in hearts of patients with Down Syndrome. Biochem Biophys Res Commun 254: 395–399
Hassold TJ, Jacobs PA (1984) Trisomy in man. Annu Rev Genet 18: 69–97
Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of DS. Proc Natl Acad Sci USA 93: 13333–13338
Jones KL (ed) (1988) Smith’s recognizable patterns of human malformation, 4th ed. WB Saunders, Philadelphia
Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazanian HH, Kucherlapati R, Atonarakis SE, Pulver AE, Housman (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92: 7612–7616
Kola I, Hertzog P (1997) Animal models in the study of the biological function of genes on HSA21 and their role in the pathophysiology of DS. Hum Mol Genet 6:1713–1727
Kola I, Herzog PJ (1998) Down Syndrome in mouse models. Curr Opin Genet Dev 8: 316–321
Kola I, Pritchard M (1999) Animal models of Down syndrome. Mol Med Today 5: 276–277
Korenberg JR, Bradley C, Disteche CM (1992) Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet 50: 294–302
Kurnit DM, Aldridge JF, Matsuoka R, Matthysse S (1985) Increased adhesiveness of trisomy 21 cells and atrioventricular canal malformations in Down syndrome: a stochastic model. Am J Med Genet 30: 385–399
Langenbeck U, Blum E, Wilkert-Walter C, Hansmann (1984) Developmental pathogenesis of chromosome disorders: report on two newly recognized signs of Down syndrome. Am J Med Genet 18: 223–230
Lee LG, Jackson JF (1972) Diagnosis of Down’s syndrome: clinical versus laboratory. Clin Pediatr 11: 353–356
Li J, Xu M, Zhou H, Ma J, Potter H (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90: 917–927
Mueller RF, Young ID (1998) Chromosome disorders. In: Emery’s Elements of Medical Genetics. Churchill Livinstone, pp 245–264
Opitz J (1982) The developmental field concept in clinical genetics. J Pediatr 101: 805–809
Oster-Granite ML, Lacey-Casem ML (1995) Neurotransmitter alterations in the trisomy 16 mouse: a genetic model system for studies of Down syndrome. MRDD Res Rev 1: 227–236
Paoloni-Giacobino A, Chen H, Antonarakis SE (1997) Cloning of a novel human neural cell adhesion molecule gene (NCAM2) that maps to chromosome region 21q21 and is potentially involved in Down syndrome. Genomics 43: 43–51
Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC (1998) Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Ann Neurol 43: 380–383
Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmid C, Bronson RT, Davisson M (1995) A mouse model for DS exhibits learning and behaviour deficits. Nat Genet 11: 177–184
Sago H, Carlson EJ, Smith D, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT (1998) TslCje, a partial trisomy 16 mouse model for DS, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 95: 6256–6261
Sakata K, Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R (1997) Commonly deleted regions on the long arm of chromosome 21 in differentiated adenocarcinoma of the stomach. Genes Chromosomes Cancer 18: 318–321
Satge D, Sasco AJ, Geneix A, Malet P (1998a) Another reason to look for tumor suppressor genes on chromosome 21. Genes Chromosomes Cancer 21: 1
Satge D, Sasco AJ, Carlsen NL, Stiller CA, Rubie H, Hero B, de Bernardi B, de Kraker J, Coze C, Kogner P, Langmark F, Hakvoort-Cammel FG, Beck D, von der Weid N, Parkes S, Hartmann O, Lippens RJ, Kamps WA, Sommelet D (1998b) A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res 58: 448–452
Shapiro BL (1975) Amplified developmental instability in Down’s syndrome. Ann Hum Genet 38: 429–437
Shapiro BL (1983) Down syndrome-A disruption of homeostasis. Am J Med Genet 14: 241–296
Shapiro BL (1989) The pathogenesis of aneuploid phenotypes: the fallacy of explanatory reductionism. Am J Med Genet 33: 146–150
Shapiro BL (1994) The environmental basis of the Down syndrome phenotype. Dev Med Child Neurol 36: 84–90
Shen JJ, Williams BJ, Zipursky A, Doyle J, Sherman SL, Jacobs PA, Shugar AL, Soukup SW, Hassold TJ (1995) Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet 56: 915–925
Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O’Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM (1997) Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 16: 28–36
Trauner DA, Bellugi U, Chase C (1989) Neurologic features of Williams and Down syndromes. Pediatr Neurol 5: 166–168
Wilson L, Curtis A, Korenberg JR, Schipper RD, Allan L, Chenevix-Trench G, Stephenson A, Goodship J, Burn J (1993) A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet 53: 1262–1268
Witkop CJ Jr, Keenan KM, Cervenka J, Jaspers MT (1988) Taurodontism: an anomaly of teeth reflecting disruptive developmental homeostasis. Am J Med Genet [Suppl]4: 85–97
Yamakawa K, Huot YK, Haendelt MA, Hubert R, Chen XN, Lyons GE, Korenberg JR (1998) DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system. Hum Mol Genet 7: 227–237
Zihni L (1994) Down’s syndrome, interferon sensitivity and the development of leukaemia. Leuk Res 18: 1–6
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this paper
Cite this paper
Pritchard, M.A., Kola, I. (1999). The “gene dosage effect” hypothesis versus the “amplified developmental instability” hypothesis in Down syndrome. In: Lubec, G. (eds) The Molecular Biology of Down Syndrome. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6380-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6380-1_20
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83377-3
Online ISBN: 978-3-7091-6380-1
eBook Packages: Springer Book Archive